Anmelden Kostenlos registrieren

AMAG Pharmaceuticals Auf den Markt gebrachte Aktien

Was ist das Auf den Markt gebrachte Aktien von AMAG Pharmaceuticals?

Auf den Markt gebrachte Aktien von AMAG Pharmaceuticals, Inc. ist 33.751M 97.20%

Was ist die Definition von Auf den Markt gebrachte Aktien?

Der Aktien-Float- Anteil ist der Anteil der Aktien einer Gesellschaft, der sich in der Hand öffentlicher Investoren befindet, im Gegensatz zu den gesperrten Stücken

Shares float represents the portion of shares of a corporation that are in the hands of public investors as opposed to locked-in stock held by promoters, company officers, controlling-interest investors, or government. This number is sometimes seen as a better way of calculating market capitalization because it provides a more accurate reflection of what public investors consider the company to be worth. In this context, the float may refer to all the shares outstanding that can be publicly traded

The float is calculated by subtracting the locked-in shares from outstanding shares. Stocks with smaller floats tend to be more volatile than those with larger floats. In general, the large holdings of founding shareholders, corporate cross-holdings, and government holdings in partially privatized companies are excluded when calculating the size of a public float.

Auf den Markt gebrachte Aktien von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu AMAG Pharmaceuticals

Was macht AMAG Pharmaceuticals?

AMAG Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. The firm focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. Its products include Intrarosa, Vyleesi, Makena, CBR, Feraheme, and MuGard. The company was founded on November 9, 1981 and is headquartered in Waltham, MA.

Unternehmen mit auf den markt gebrachte aktien ähnlich AMAG Pharmaceuticals